The hepatitis B is a virus, which invades the liver. The rest of the population has a chance to eliminate the virus independently and other a chronic infection may cause an irreparable damage to the liver, cirrhosis or liver cancer. Early diagnosis and treatment are the main dimensions of liver health precaution and management of complications.
The symptoms are exhibited in the majority of people who have no prior infections. You can observe in the case of the symptoms appearance:
Transmission of the virus takes place when the blood or body fluids of the virus is infected and comes into contact with the blood of another person who is uninfected. Common routes include:
GastroDoxs has patient-focused care and overall treatment and care of Hepatitis B in Houston and can offer you the knowledge in diagnostics and effective managerial solutions to treatment of Hepatitis B that involve the antiviral treatment, vaccination and regular liver tests to ensure that you have long-term health of the liver in hepatitis. The personalized and caring services you receive give you support and advice in each of the steps that you go through. An appointment and counseling about hepatitis B with a specialist have been made.
We've successfully treated more than 788 patients, helping individuals improve their digestive health and overall well-being through expert, personalized care.
With over 20 years of experience, GastroDoxs has been a trusted provider of gastroenterology care, focusing on delivering the best outcomes for patients
Dr. Bharat Pothuri is a Board-Certified Gastroenterologist and Hepatologist. With extensive experience in digestive health, he specializes in advanced endoscopic procedures, chronic GI disorder management, and preventive care. Dr. Pothuri is dedicated to providing expert, patient-focused insights to help improve gut health and overall well-being.
Diagnosis of hepatitis B is by blood tests to determine the presence of the virus in the body and the viral load by detecting the presence of the antigen of the hepatitis B surface antigen (HBsAg), anti-Hepatitis B surface antibody (anti-HBs) and quantitative viral markers (HBV DNA or quantitative antibody levels).
The initial symptoms may be minimal and they may be absent. They can be observed in cases of fatigue, anorexia, nausea and vomiting, black urine, pale feces and mild jaundice (yellowish skin or eyes).
Yes. The infection is self-limiting in the majority of the adults, however, approximately 5-10 percent adults are infected with chronic hepatitis B that may cause permanent inflammation of the liver, fibrosis or liver cirrhosis in case there is no curing of the infection.
The tenofivir and entecavir are the antiviral drugs that are usually used to contain the viral replications with the aim of preserving the liver functioning as well as decreasing the likelihood of liver damage as the period continues.
Yes. An effective and a safe vaccine against the Hepatitis B infection is available. It is even suggested to all non-vaccinated infants, children belonging to the risk category, and even to the healthcare workers.
Normal adult schedule of vaccination is the three doses that are to be administered at 0, 1 and 6 months. The results of this series are long term immunity by a very high percentage of the recipients.
At the end of the series, it may be 20 years and more. Healthy adults also have a sufficient amount of antibodies without the need to have a booster but in the future, high risk individuals can undergo retesting.
The side effect is mostly mild and temporal in nature such as local soreness on the inoculation site, low grade fever or even post-vaccination fatigue, one or two days after.
GastroDoxs in Houston is a center that provides a liver disease, individual treatment plans, modernized medications and a follow-up services comprehensive which is board certified in gastroenterology.
Yes. Middle-range nutrition, alcohol and other hepatotoxic substances abstinence, physical activities, and medical consultation support the health of the liver and increase the response rate of the treatment.
